Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Share News (APH)

Share Price Information for Alliance Pharma (APH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.95
Bid: 32.65
Ask: 33.00
Change: 0.10 (0.30%)
Spread: 0.35 (1.072%)
Open: 33.25
High: 33.25
Low: 32.95
Prev. Close: 32.85
APH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Alternative Income assets fall; Aura wins conventions

Wed, 01st Feb 2023 21:04

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Alternative Income REIT PLC - London-based real estate investment company - Net asset value per share as at December 31 stands at 84.3 pence, down 13% compared to 97.0p as at September 30. Records a NAV total return of negative 11.6% versus 2.3% a quarter prior. Attributes this to a decrease in the portfolio valuation. Declares a second interim quarterly dividend of 1.375p per share for the quarter. Reconfirms its dividend target of at least 5.7pps. Rent collection remains resilient with 100% expected for the December 2022 quarter, it adds.

----------

Aura Energy Ltd - Australia-based minerals company with polymetallic and uranium projects in Europe and Africa - Signs mining conventions providing tenure security and fiscal certainty for an initial 30-year period with the government of Mauritania. Notes that this is a key milestone to support financing the development of the Tiris project. "What we see the is potential of the Tiris region in the uranium world. With the formalisation of our Mining Convention and our partnership with ANARPAM, we are keen to work with the government of Mauritania to develop the Tiris resource. Our increased knowledge and our belief in the quality of the resource gained from the drilling program and the expansion studies, to be released imminently, we believe will allow us to develop a world-class uranium operation," Chair Phil Mitchell comments.

----------

Maven Income & Growth VCT 5 PLC - London-based investment firm - Confirms that its unaudited net asset value as at November 30 amounted to 35.40 pence per share. Proposes a final dividend of 0.50 pence per share for the year that ended November 30.

----------

Maven Income & Growth VCT 3 PLC - London-based venture capital trust - Confirm that its unaudited net asset value per share as at November 30 stood at 57.32 pence per share. Proposes that a final dividend of 1.90p per share should be paid for the year ended November 30.

----------

Kodal Minerals PLC - mineral exploration and development company focused on lithium and gold assets in West Africa - Confirms the receipt of a USD7.0 million deposit agreed upon with Hainan Mining Co Ltd. This is part of a conditional funding package of USD117.8 million announced on January 19 that will provide full financing for the development and commencement of production at the Bougouni lithium project in Mali. Notes that the funding transaction remains subject to Chinese regulatory approvals, among other things.

----------

Alliance Pharma PLC - Chippenham, England-based distributor of consumer healthcare brands and prescription medicines - Promotes non-executivce director Richard Jones to senior independent director from non-executive director. He held the position since 2019, the company says. "I am also pleased to appoint Richard Jones as our first senior independent director. Richard will help support and expand our stakeholder engagement programme, building on his extensive experience in capital markets and leveraging his strong networks with shareholders," Chair David Cook says.

----------

Mkango Resources Ltd - Vancouver-based mineral exploration and development company - Signs definitive agreements with CoTec Holdings Corp in relation to a GBP2 million convertible loan agreement in Mkango, a GBP1.5 million equity investment in Maginito, and a co-operation agreement regarding future investments in rare earth processing technology opportunities in the US, subject to closing.

----------

Valeura Energy Inc - Calgary, Canada-based upstream oil & gas company - Raises CAD10 million, or GBP6.1 million, in a private placement of 3.9 million shares at CAD2.54 each. Says that the net proceeds from will be used to fund the company's pre-production operations at the Wassana field and its Wassana infill drilling programme and for general corporate purposes. Expects the closing of the offering to occur on or about February 9.

----------

Vulcan Industries PLC - London-based engineering services firm - Records revenue of GBP968,000 in the nine months to year-end, changed from a year before. Pretax loss in the period narrows to GBP697,000 from GBP1.0 million a year before. Notes that it identified further potential additional acquisition opportunities and will make further announcements as this progress.

----------

Advanced Medical Solutions Group PLC - Cheshire, England-based developer and maker of tissue-healing technology - Buys Connexicon Medical Ltd for an up-front payment of EUR7 million with further deferred payments, dependent on the delivery of certain "research & development, regulatory and commercial milestones between 2023 and 2027." "The acquisition will unlock significant commercial, R&D, regulatory, marketing and operational synergies that we are confident will enhance the scope of both companies. We are excited to add more tissue sealant expertise, products and brands to the AMS franchise ensuring that we remain at the forefront of this expanding market," Chief Executive Chris Meredith comments.

----------

By Abby Amoakuh, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
20 Mar 2018 16:14

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 21 March KingfisherFull Year ResultsAlpha FXFull Year In SportFull 22

Read more
8 Mar 2018 15:16

CANADA STOCKS-TSX recovers as Trump promise of flexibility eases tariff fears

By Nichola Saminather TORONTO, March 8 (Reuters) - Canada's main stock index advanced on Thursday, with all sectors but one in on receding of a

Read more
23 Jan 2017 14:34

Alliance Pharma to more than double revenue in 2016 results

(ShareCast News) - Specialty pharmaceutical company Alliance Pharma announced its pre-close trading update ahead of its preliminary results for the year to 31 December on Monday. The AIM-traded firm said group revenue for 2016 was now expected to be more than double the prior year at £97.5m. It sai

Read more
14 Sep 2016 08:05

Alliance Pharma H1 profit doubles after acquisition

(ShareCast News) - Alliance Pharma posted a jump in first-half profit and revenue as it benefited from the acquisition of the Sinclair Healthcare Products business last year. In the six months to the end of June, pre-tax profit surged 113% to £11.7m on revenue of £46.4m, up 104% from the first half

Read more
19 Jul 2016 09:15

Alliance Pharma sales more than double on Sinclair acquisition

(ShareCast News) - Specialty pharmaceutical company Alliance Pharma said its sales more than doubled in the six months ended 30 June thanks to its acquisition of the Sinclair Healthcare Products business in December last year. Sales rose to £46.4m from £22.8m, with Sinclair products contributing £20

Read more
19 Jul 2016 08:26

First Half Revenue Surges For Alliance Pharma And Sinclair Pharma

Read more
12 Jul 2016 15:12

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
6 Jul 2016 15:03

UK Dividends Calendar - Next 7 Days

Read more
5 Jul 2016 15:04

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
9 Jun 2016 15:02

UK Dividends Calendar - Next 7 Days

Read more
25 May 2016 08:18

Alliance Pharma Confident For 2016 As First Four Months In Line

Read more
18 May 2016 15:05

AGM, EGM Calendar - Week Ahead

Read more
5 May 2016 12:42

DIRECTOR DEALINGS: Alliance Pharma Non-Executive Acquires First Shares

Read more
7 Apr 2016 14:42

Alliance Pharma 2015 profit up on Sinclair Healthcare acquisition

(ShareCast News) - Alliance Pharma posted a rise in 2015 pre-tax profit as revenue grew following its acquisition of the Sinclair Healthcare Products division. For the year to the end of December, pre-tax profit increased 49% to £15.2m as revenue rose 11% to £48.3m. This included £0.8m from the "tra

Read more
7 Apr 2016 07:31

Alliance Pharma 2015 Profit Boosted By Sinclair Healthcare Buy

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.